Citations (8)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Xiangyang Ye, Rongxian Qiu, Xiongzhi He, Zhengting Hu, Fengfeng Zheng, Xiaogang Huang, Xuemei Xie, Feihua Chen, Hangbing Ou & Guoxian Lin. (2022) miR-647 inhibits hepatocellular carcinoma cell progression by targeting protein tyrosine phosphatase receptor type F. Bioengineered 13:1, pages 1090-1102.
Read now
Read now
Articles from other publishers (7)
Renrui Zou, Yaqian Liu, Sangsang Qiu, Ya Lu, Yan Chen, Hui Yu, Hangju Zhu, Wenbo Zhu, Longbiao Zhu, Jifeng Feng & Jing Han. (2023) The identification of N6-methyladenosine-related miRNAs predictive of hepatocellular carcinoma prognosis and immunotherapy efficacy. Cancer Biomarkers 38:4, pages 551-566.
Crossref
Crossref
Srinivasulu Yerukala Sathipati, Nikhila Aimalla, Ming-Ju Tsai, Tonia Carter, Sohyun Jeong, Zhi Wen, Sanjay K Shukla, Rohit Sharma & Shinn-Ying Ho. (2023) Prognostic microRNA signature for estimating survival in patients with hepatocellular carcinoma. Carcinogenesis 44:8-9, pages 650-661.
Crossref
Crossref
Masoumeh Hajizadeh, Farnaz Hajizadeh, Sevil Ghaffarei, Mohammad Amin Doustvandi, Khadijeh Hajizadeh, Seyyed Mohammad Yaghoubi, Fateme Mohammadnejad, Nadia Allahyarzadeh Khiabani, Pegah Mousavi & Behzad Baradaran. (2023) MicroRNAs and their vital role in apoptosis in hepatocellular carcinoma: miRNA-based diagnostic and treatment methods. Gene 888, pages 147803.
Crossref
Crossref
Hanbin Wang, Luxuan Wang, Yanli Tan, Chuan Fang, Chunhui Li & Lijian Zhang. (2023) Identification of miRNAs Involved in Intracranial Aneurysm Rupture in Cigarette-Smoking Patients. Neurology and Therapy 12:6, pages 2101-2119.
Crossref
Crossref
Desh Deepak Singh, Youngsun Kim, Seung Ah Choi, Ihn Han & Dharmendra Kumar Yadav. (2023) Clinical Significance of MicroRNAs, Long Non-Coding RNAs, and CircRNAs in Cardiovascular Diseases. Cells 12:12, pages 1629.
Crossref
Crossref
Zhongji Zhang, Fengbo Li, Yan Li, Zhong Li & Guangwei Jia. (2023) In vitro Anti-malignant Property of PCMT1 Silencing and Identification of the SNHG16/miR-195/PCMT1 Regulatory Axis in Breast Cancer Cells. Clinical Breast Cancer 23:3, pages 302-316.
Crossref
Crossref
Wei Chen, Junnan Ru, Tong Wu, Da Man, Jingbang Wu, Lijuan Wu, Yujing Sun, Hanxi Yu, Min Li, Gangwei Zhang, Xingxin Zhu, Rongliang Tong, Heng Xiao, Yanhua Li & Beng Yang. (2023) MiR-652-3p promotes malignancy and metastasis of cancer cells via inhibiting TNRC6A in hepatocellular carcinoma. Biochemical and Biophysical Research Communications 640, pages 1-11.
Crossref
Crossref